Early fetal hypoxia leads to growth restriction and myocardial thinning

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 295, Issue 2, 2008, Pages

  Ream, Margie ^a   Ray, Alisa M ^a   Chandra, Rashmi ^a,b   Chikaraishi, Dona M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Epicardium; Human intrauterine growth restriction; Hypoxia inducible transcription factor 1; Insulin like growth factor binding protein 1; Myocardium

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; FETOPROTEIN; OXYGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR RISK; EPO GENE; FEMALE; FETUS; FETUS DEVELOPMENT; FETUS HYPOXIA; FETUS WEIGHT; FOOD INTAKE; GENE; GENE EXPRESSION; GLUT 1 GENE; HEART FAILURE; HEART MUSCLE INJURY; IGFBP 1 GENE; INTRAUTERINE GROWTH RETARDATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PRIORITY JOURNAL; TISSUE OXYGENATION; VEGF GENE; ANIMAL; ANIMAL FOOD; BLOOD; CELL PROLIFERATION; DISEASE MODEL; FETUS DEATH; GENETIC TRANSCRIPTION; GENETICS; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; HEART; HEART MUSCLE; MATERNAL NUTRITION; METABOLISM; OXYGEN CONSUMPTION; PATHOLOGY; PATHOPHYSIOLOGY; PERICARDIUM; PLACENTA CIRCULATION; PREGNANCY; PRENATAL DEVELOPMENT;

ANIMAL NUTRITION PHYSIOLOGY; ANIMALS; BLOOD GLUCOSE; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; FEMALE; FETAL DEATH; FETAL GROWTH RETARDATION; FETAL HYPOXIA; FETAL PROTEINS; FETAL WEIGHT; FETUS; GESTATIONAL AGE; HEART; HEART FAILURE; HYPOXIA-INDUCIBLE FACTOR 1; MATERNAL NUTRITION PHYSIOLOGY; MICE; MYOCARDIUM; OXYGEN; OXYGEN CONSUMPTION; PERICARDIUM; PLACENTAL CIRCULATION; PREGNANCY; TRANSCRIPTION, GENETIC;

EID: 51149120779     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00771.2007     Document Type: Article

References (89)

1. Anderson RN. Deaths: leading causes for 2000. Natl Vital Stat Rep 50: 1-85, 2002.
2. Arbeille P, Maulik D, Salihagic A, Locatelli A, Lansac J, Platt LD. Effect of long-term cocaine administration to pregnant ewes on fetal hemodynamics, oxygenation, and growth. Obstet Gynecol 90: 795-802, 1997.
3. Ashwal S, Majcher JS, Longo LD. Patterns of fetal lamb regional cerebral blood flow during and after prolonged hypoxia: studies during the posthypoxic recovery period. Am J Obstet Gynecol 139: 365-372, 1981.
4. Baker J, Liu JP, Robertson EJ, Efstratiadis A. Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75: 73-82, 1993.
5. Banerjee RR, Rangwala SM, Shapiro JS, Rich AS, Rhoades B, Qi Y, Wang J, Rajala MW, Pocai A, Scherer PE, Steppan CM, Ahima RS, Obici S, Rossetti L, Lazar MA. Regulation of fasted blood glucose by resistin. Science 303: 1195-1198, 2004.
6. Barker DJ. The fetal origins of coronary heart disease. Eur Heart J 18: 883-884, 1997.
7. Barker DJ, Osmond C, Golding J, Kuh D, Wadsworth ME. Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. BMJ 298: 564-567, 1989.
8. Boksa P, El-Khodor BF. Birth insult interacts with stress at adulthood to alter dopaminergic function in animal models: possible implications for schizophrenia and other disorders. Neurosci Biobehav Rev 27: 91-101, 2003.
9. Bozzetti P, Ferrari MM, Marconi AM, Ferrazzi E, Pardi G, Makowski EL, Battaglia FC. The relationship of maternal and fetal glucose concentrations in the human from midgestation until term. Metabolism 37: 358-363, 1988.
10. Bulterys MG, Greenland S, Kraus JF. Chronic fetal hypoxia and sudden infant death syndrome: interaction between maternal smoking and low hematocrit during pregnancy. Pediatrics 86: 535-540, 1990.
11. Chen XQ, Dong J, Niu CY, Fan JM, Du JZ. Effects of hypoxia on glucose, insulin, glucagon, and modulation by corticotropin-releasing factor receptor type 1 in the rat. Endocrinology 148: 3271-3278, 2007.
12. Clemmer TP, Telford IR. Abnormal development of the rat heart during prenatal hypoxic stress. Proc Soc Exp Biol Med 121: 800-803, 1966.
13. Cohn HE, Sacks EJ, Heymann MA, Rudolph AM. Cardiovascular responses to hypoxemia and acidemia in fetal lambs. Am J Obstet Gynecol 120: 817-824, 1974.
14. Conway SJ, Henderson DJ, Kirby ML, Anderson RH, Copp AJ. Development of a lethal congenital heart defect in the splotch (Pax3) mutant mouse. Cardiovasc Res 36: 163-173, 1997.
15. Copp AJ. Death before birth: clues from gene knockouts and mutations. Trends Genet 11: 87-93, 1995.
16. de Grauw TJ, Myers RE, Scott WJ. Fetal growth retardation in rats from different levels of hypoxia. Biol Neonate 49: 85-89, 1986.
17. Dor Y, Klewer SE, McDonald JA, Keshet E, Camenisch TD. VEGF modulates early heart valve formation. Anat Rec A Discov Mol Cell Evol Biol 271: 202-208, 2003.
18. Douglas RM, Haddad GG. Genetic models in applied physiology: invited review: effect of oxygen deprivation on cell cycle activity: a profile of delay and arrest. J Appl Physiol 94: 2068-2084, 2003.
19. Dyson E, Sucov HM, Kubalak SW, Schmid-Schonbein GW, DeLano FA, Evans RM, Ross J Jr, Chien KR. Atrial-like phenotype is associated with embryonic ventricular failure in retinoid X receptor alpha -/- mice. Proc Natl Acad Sci USA 92: 7386-7390, 1995.
20. Evans SM, Koch CJ. Prognostic significance of tumor oxygenation in humans. Cancer Lett 195: 1-16, 2003.
21. Fantel AG, Person RE, Burroughs-Gleim CJ, Mackler B. Direct embryotoxicity of cocaine in rats: effects on mitochondrial activity, cardiac function, and growth and development in vitro. Teratology 42: 35-43, 1990.
22. Fletcher AJ, Gardner DS, Edwards CM, Fowden AL, Giussani DA. Development of the ovine fetal cardiovascular defense to hypoxemia towards full term. Am J Physiol Heart Circ Physiol 291: H3023-H3034, 2006.
23. Gardner DS, Fletcher AJ, Bloomfield MR, Fowden AL, Giussani DA. Effects of prevailing hypoxaemia, acidaemia or hypoglycaemia upon the cardiovascular, endocrine and metabolic responses to acute hypoxaemia in the ovine fetus. J Physiol 540: 351-366, 2002.
24. Giaccia AJ, Simon MC, Johnson R. The biology of hypoxia: the role of oxygen sensing in development, normal function, and disease. Genes Dev 18: 2183-2194, 2004.
25. Giussani DA. Hypoxia, fetal growth and developmental origins of health and disease. In: Early Life Origins of Health and Disease, edited by Wintour E and Owens JA. New York, NY: Springer Verlag, 2006, p. 219-224.
26. Huang ST, Vo KC, Lyell DJ, Faessen GH, Tulac S, Tibshirani R, Giaccia AJ, Giudice LC. Developmental response to hypoxia. FASEB J 18: 1348-1365, 2004.
27. Ingalls TH, Curley FJ, Prindle RA. Experimental production of congenital anomalies; timing and degree of anoxia as factors causing fetal deaths and congenital anomalies in the mouse. N Engl J Med 247: 758-768, 1952.
28. Iwamoto HS, Kaufman T, Keil LC, Rudolph AM. Responses to acute hypoxemia in fetal sheep at 0.6-0.7 gestation. Am J Physiol Heart Circ Physiol 256: H613-H620, 1989.
29. Jaber M, Koch WJ, Rockman H, Smith B, Bond RA, Sulik KK, Ross J Jr, Lefkowitz RJ, Caron MG, Giros B. Essential role of β-adrenergic receptor kinase 1 in cardiac development and function. Proc Natl Acad Sci USA 93: 12974-12979, 1996.
30. Jackson BT, Piasecki GJ, Novy MJ. Fetal responses to altered maternal oxygenation in rhesus monkey. Am J Physiol Regul Integr Comp Physiol 252: R94-R101, 1987.
31. Jaffee OC. The effects of moderate hypoxia and moderate hypoxia plus hypercapnea on cardiac development in chick embryos. Teratology 10: 275-281, 1974.
32. 2 in the chronically catheterized fetal sheep. Am J Obstet Gynecol 134: 776-783, 1979.
33. Jensen GM, Moore LG. The effect of high altitude and other risk factors on birthweight: independent or interactive effects? Am J Public Health 87: 1003-1007, 1997.
34. Kwee L, Baldwin HS, Shen HM, Stewart CL, Buck C, Buck CA, Labow MA. Defective development of the embryonic and extraembryonic circulatory systems in vascular cell adhesion molecule (VCAM-1) deficient mice. Development 121: 489-503, 1995.
35. Lavine KJ, Yu K, White AC, Zhang X, Smith C, Partanen J, Ornitz DM. Endocardial and epicardial derived FGF signals regulate myocardial proliferation and differentiation in vivo. Dev Cell 8: 85-95, 2005.
36. Lee YM, Jeong CH, Koo SY, Son MJ, Song HS, Bae SK, Raleigh JA, Chung HY, Yoo MA, Kim KW. Determination of hypoxic region by hypoxia marker in developing mouse embryos in vivo: A possible signal for vessel development. Dev Dyn 220: 175-186, 2001.
37. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75: 59-72, 1993.
38. Lueder FL, Kim SB, Buroker CA, Bangalore SA, Ogata ES. Chronic maternal hypoxia retards fetal growth and increases glucose utilization of select fetal tissues in the rat. Metab Clin Exp 44: 532-537, 1995.
39. McLellan KC, Hooper SB, Bocking AD, Delhanty PJ, Phillips ID, Hill DJ, Han VK. Prolonged hypoxia induced by the reduction of maternal uterine blood flow alters insulin-like growth factor-binding protein-1 (IGFBP-1) and IGFBP-2 gene expression in the ovine fetus. Endocrinology 131: 1619-1628, 1992.
40. Merki E, Zamora M, Raya A, Kawakami Y, Wang J, Zhang X, Burch J, Kubalak SW, Kaliman P, Belmonte JC, Chien KR, Ruiz-Lozano P. Epicardial retinoid X receptor alpha is required for myocardial growth and coronary artery formation. Proc Natl Acad Sci USA 102: 18455-18460, 2005.
41. Miller MW, Nowakowski RS. Use of bromodeoxyuridine- immunohistochemistry to examine the proliferation, migration and time of origin of cells in the central nervous system. Brain Res 457: 44-52, 1988.
42. Milley JR. Protein synthesis during hypoxia in fetal lambs. Am J Physiol Endocrinol Metab 252: E519-E524, 1987.
43. Mima T, Ueno H, Fischman DA, Williams LT, Mikawa T. Fibroblast growth factor receptor is required for in vivo cardiac myocyte proliferation at early embryonic stages of heart development. Proc Natl Acad Sci USA 92: 467-471, 1995.
44. Moore LG. Fetal growth restriction and maternal oxygen transport during high altitude pregnancy. High Alt Med Biol 4: 141-156, 2003.
45. Morgenbesser SD, Schreiber-Agus N, Bidder M, Mahon KA, Overbeek PA, Horner J, DePinho RA. Contrasting roles for c-Myc and L-Myc in the regulation of cellular growth and differentiation in vivo. EMBO J 14: 743-756, 1995.
46. Mulder AL, Golde JM, Goor AA, Giussani DA, Blanco CE. Developmental changes in plasma catecholamine concentrations during normoxia and acute hypoxia in the chick embryo. J Physiol 527: 593-599, 2000.
47. Pasumarthi KB, Field LJ. Cardiomyocyte cell cycle regulation. Circ Res 90: 1044-1054, 2002.
48. Pennisi DJ, Ballard VL, Mikawa T. Epicardium is required for the full rate of myocyte proliferation and levels of expression of myocyte mitogenic factors FGF2 and its receptor, FGFR-1, but not for transmural myocardial patterning in the embryonic chick heart. Dev Dyn 228: 161-172, 2003.
49. Popovici RM, Lu M, Bhatia S, Faessen GH, Giaccia AJ, Giudice LC. Hypoxia regulates insulin-like growth factor-binding protein 1 in human fetal hepatocytes in primary culture: suggestive molecular mechanisms for in utero fetal growth restriction caused by uteroplacental insufficiency. J Clin Endocrinol Metab 86: 2653-2659, 2001.
50. Portbury AL, Chandra R, Groelle M, McMillian MK, Elias A, Herlong JR, Rios M, Roffler-Tarlov S, Chikaraishi DM. Catecholamines act via a beta-adrenergic receptor to maintain fetal heart rate and survival. Am J Physiol Heart Circ Physiol 284: H2069-H2077, 2003.
51. Raleigh JA, Chou SC, Arteel GE, Horsman MR. Comparisons among pimonidazole binding, oxygen electrode measurements, and radiation response in C3H mouse tumors. Radiat Res 151: 580-589, 1999.
52. Ratcliffe PJ, O'Rourke JF, Maxwell PH, Pugh CW. Oxygen sensing, hypoxia-inducible factor-1 and the regulation of mammalian gene expression. J Exp Biol 201: 1153-1162, 1998.
53. Regula KM, Ens K, Kirshenbaum LA. Inducible expression of BNIP3 provokes mitochondrial defects and hypoxia-mediated cell death of ventricular myocytes. Circ Res 91: 226-231, 2002.
54. Rossant J. Mouse mutants and cardiac development: new molecular insights into cardiogenesis. Circ Res 78: 349-353, 1996.
55. Schipani E, Ryan HE, Didrickson S, Kobayashi T, Knight M, Johnson RS. Hypoxia in cartilage: HIF-1α is essential for chondrocyte growth arrest and survival. Genes Dev 15: 2865-2876, 2001.
56. Schuijers JA, Walker DW, Browne CA, Thorburn GD. Effect of hypoxemia on plasma catecholamines in intact and immunosympathectomized fetal lambs. Am J Physiol Regul Integr Comp Physiol 251: R893-R900, 1986.
57. Semenza GL. HIF-1 and mechanisms of hypoxia sensing. Curr Opin Cell Biol 13: 167-171, 2001.
58. Sharma SK, Lucitti JL, Nordman C, Tinney JP, Tobita K, Keller BB. Impact of hypoxia on early chick embryo growth and cardiovascular function. Pediatr Res 59: 116-120, 2006.
59. Soonpaa MH, Kim KK, Pajak L, Franklin M, Field LJ. Cardiomyocyte DNA synthesis and binucleation during murine development. Am J Physiol Heart Circ Physiol 271: H2183-H2189, 1996.
60. Soothill PW, Nicolaides KH, Rodeck CH, Gamsu H. Blood gases and acid-base status of the human second-trimester fetus. Obstet Gynecol 68: 173-176, 1986.
61. Stowe DF, Bosnjak ZJ, Kampine JP. Effects of hypoxia on adult and neonatal pacemaker rates. Obstet Gynecol 66: 649-656, 1985.
62. Stuckmann I, Evans S, Lassar AB. Erythropoietin and retinoic acid, secreted from the epicardium, are required for cardiac myocyte proliferation. Dev Biol 255: 334-349, 2003.
63. Su JY, Friedman WF. Comparison of the responses of fetal and adult cardiac muscle to hypoxia. Am J Physiol 224: 1249-1253, 1973.
64. Sucov HM, Dyson E, Gumeringer CL, Price J, Chien KR, Evans RM. RXRα mutant mice establish a genetic basis for vitamin A signaling in heart morphogenesis. Genes Dev 8: 1007-1018, 1994.
65. Sugishita Y, Leifer DW, Agani F, Watanabe M, Fisher SA. Hypoxia-responsive signaling regulates the apoptosis-dependent remodeling of the embryonic avian cardiac outflow tract. Dev Biol 273: 285-296, 2004.
66. Sugishita Y, Watanabe M, Fisher SA. Role of myocardial hypoxia in the remodeling of the embryonic avian cardiac outflow tract. Dev Biol 267: 294-308, 2004.
67. Takahashi T, Nowakowski RS, Caviness VS Jr. BUdR as an S-phase marker for quantitative studies of cytokinetic behaviour in the murine cerebral ventricular zone. J Neurocytol 21: 185-197, 1992.
68. Takahashi T, Nowakowski RS, Caviness VS Jr. The cell cycle of the pseudostratified ventricular epithelium of the embryonic murine cerebral wall. J Neurosci 15: 6046-6057, 1995.
69. Tansey EE, Kwaku KF, Hammer PE, Cowan DB, Federman M, Levitsky S, McCully JD. Reduction and redistribution of gap and adherens junction proteins after ischemia and reperfusion. Ann Thorac Surg 82: 1472-1479, 2006.
70. Tapanainen PJ, Bang P, Wilson K, Unterman TG, Vreman HJ, Rosenfeld RG. Maternal hypoxia as a model for intrauterine growth retardation: effects on insulin-like growth factors and their binding proteins. Pediatr Res 36: 152-158, 1994.
71. Tazuke SI, Mazure NM, Sugawara J, Carland G, Faessen GH, Suen LF, Irwin JC, Powell DR, Giaccia AJ, Giudice LC. Hypoxia stimulates insulin-like growth factor binding protein 1 (IGFBP-1) gene expression in HepG2 cells: a possible model for IGFBP-1 expression in fetal hypoxia. Proc Natl Acad Sci USA 95: 10188-10193, 1998.
72. Thandroyen FT, Muntz K, Rosenbaum T, Ziman B, Willerson JT, Buja LM. β-Receptor-adenylate cyclase coupling in hypoxic neonatal rat ventricular myocytes. Am J Physiol Heart Circ Physiol 256: H1209-H1217, 1989.
73. Tomanek RJ, Ratajska A, Kitten GT, Yue X, Sandra A. Vascular endothelial growth factor expression coincides with coronary vasculogenesis and angiogenesis. Dev Dyn 215: 54-61, 1999.
74. Towbin JA, Bowles NE. The failing heart. Nature 415: 227-233, 2002.
75. Toyoda M, Shirato H, Nakajima K, Kojima M, Takahashi M, Kubota M, Suzuki-Migishima R, Motegi Y, Yokoyama M, Takeuchi T. Jumonji downregulates cardiac cell proliferation by repressing cyclin D1 expression. Dev Cell 5: 85-97, 2003.
76. Unger C, Weiser JK, McCullough RE, Keefer S, Moore LG. Altitude, low birth weight, and infant mortality in Colorado. JAMA 259: 3427-3432, 1988.
77. Walton MI, Bleehen NM, Workman P. Effects of localised tumour hyperthermia on pimonidazole (Ro 03-8799) pharmacokinetics in mice. Br J Cancer 59: 667-673, 1989.
78. Webster KA, Bishopric NH. Molecular regulation of cardiac myocyte adaptations to chronic hypoxia. J Mol Cell Cardiol 24: 741-751, 1992.
79. 2-regulated gene expression. FASEB J 16: 1151-1162, 2002.
80. White MM, Zhang L. Effects of chronic hypoxia on maternal vasodilation and vascular reactivity in guinea pig and ovine pregnancy. High Alt Med Biol 4: 157-169, 2003.
81. Wildenthal K. Long-term maintenance of spontaneously beating mouse hearts in organ culture. J Appl Physiol 30: 153-157, 1971.
82. Williams SJ, Campbell ME, McMillen IC, Davidge ST. Differential effects of maternal hypoxia or nutrient restriction on carotid and femoral vascular function in neonatal rats. Am J Physiol Regul Integr Comp Physiol 288: R360-R367, 2005.
83. Wu H, Lee SH, Gao J, Liu X, Iruela-Arispe ML. Inactivation of erythropoietin leads to defects in cardiac morphogenesis. Development 126: 3597-3605, 1999.
84. Xiao D, Ducsay CA, Zhang L. Chronic hypoxia and developmental regulation of cytochrome c expression in rats. J Soc Gynecol Investig 7: 279-283, 2000.
85. Xu Y, Williams SJ, O'Brien D, Davidge ST. Hypoxia or nutrient restriction during pregnancy in rats leads to progressive cardiac remodeling and impairs postischemic recovery in adult male offspring. FASEB J 20: 1251-1253, 2006.
86. Yang JT, Rayburn H, Hynes RO. Cell adhesion events mediated by alpha 4 integrins are essential in placental and cardiac development. Development 121: 549-560, 1995.
87. Zagorska A, Dulak J. HIF-1: the knowns and unknowns of hypoxia sensing. Acta Biochim Pol 51: 563-585, 2004.
88. Zeevi-Levin N, Barac YD, Reisner Y, Reiter I, Yaniv G, Meiry G, Abassi Z, Kostin S, Schaper J, Rosen MR, Resnick N, Binah O. Gap junctional remodeling by hypoxia in cultured neonatal rat ventricular myocytes. Cardiovasc Res 66: 64-73, 2005.
89. Zhang L. Prenatal hypoxia and cardiac programming. J Soc Gynecol Investig 12: 2-13, 2005.